NCT06895551View on ClinicalTrials.gov

Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection

CompletedOBSERVATIONAL

Enrollment

1,069

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

May 1, 2024

Study Completion Date

February 20, 2025

Conditions

Esophageal Cancer

Trial Locations (1)

Unknown

Cancer hospital, Chinese academy of medical sciences, Beijing

All Listed Sponsors

lead

Singlera Genomics Inc.

INDUSTRY